Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters
Part of paid clinical trials in Wilmington, Delaware.
- Sponsor
- Summa Therapeutics, LLC
- Study ID
- NCT06906055
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Peripheral Arterial Disease Below the Knee
- Peripheral Arterial Disease, Rutherford 4 and 5 with Possibility to Improve Vascularization
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Not accepted
Interventions
- Multicath — DEVICEUse of a multifunctional catheter for revascularization of blocked arteries below the knee
- Standard of Care (SOC) — DEVICEUse of single function crossing catheters, diagnostic catheters, angioplasty balloon catheters
Study Details
Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters ("BTK Multicath Registry") A non-randomized clinical registry This study is designed to obtain preliminary data on clinically relevant procedural variables during percutaneous below-knee artery revascularization procedures among consecutive patients treated with either the Finesse BTK Multicath® ("Finesse") or the standard of care using conventional angioplasty balloon catheters. This registry will enroll participants with a history of chronic limb threatening ischemia and below-knee arterial insufficiency who will be assigned to revascularization with or without use of the Finesse BTK Multicath. The registry is an acute study examining procedural data only. The primary endpoints of interest are the volume of contrast used for the intervention, overall procedure time, radiation dose, number of catheter exchanges during revascularization, and medical device supply costs. For the first phase 12 consecutive patients will be treated with the standard of care. For the second phase 12 consecutive patients will be treated with Finesse. 24 participants total Up to 5 study sites in the United States Initial anticipated enrollment: Q4 2024 Last anticipated enrollment: Q2 2025 Patients \>=18 years old with documented history of unilateral chronic limb threatening ischemia due to below-knee arterial insufficiency with angiographic runoff in the foot and limited arterial insufficiency above the knee 1. Contrast volume administered during the revascularization portion of a procedure. 2. Number of catheter exchanges during revascularization 3. Fluoroscopy time 4. Radiation dose during revascularization 5. Procedure time post-enrollment 6. Equipment costs 7. Reduced use of supplies 8. Technical success 9. Safety/Major Adverse Peripheral Events On-treatment sample Intention-to-treat
Key Dates
- Start date
- Apr 3, 2025
- Status verified
- Mar 2025
- Primary completion
- Dec 31, 2025
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Standard of careUse of conventional single function crossing catheters, diagnostic catheters, angioplasty balloon catheters
- Experimental: Finesse BTK MulticathUse of a multifunctional revascularization catheter
Primary Outcome Measure
Contrast volume [ Time Frame: during the intervention/procedure/surgery ]
Central Contacts
- Timothy Murphy, M.D.8772672685
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Endovascular Consultants | Wilmington | Delaware | 19805 | |
| Atlantic Medical Imaging | Vineland | New Jersey | 08360 |